Conference Coverage
Conference Coverage
Shift Needed in Research, Treatment, Care for Aging MS Population
Independent of disease progression, the impact of aging on MS has been underappreciated in research and in clinical practice.
Conference Coverage
Prospective MS Trial Proves Ocrelizumab Efficacy in Under-Represented Populations
A prospective phase 4 clinical trial that recruited solely Black and Hispanic patients could shed light on divergent treatment outcomes.
Conference Coverage
Pediatric Ocrelizumab Dose Established for MS
Pharmacokinetic and pharmacodynamic data show that adult dose is safe and effective for most children.
Conference Coverage
The Positive Effects of Exercise in MS
Conference Coverage
MS in Men: Unusual, and Unusually Challenging
The clinical course is different in men, but it can be challenging to get them to talk about their symptoms.
Conference Coverage
Investigational MS Med Nearly Eliminates Disease Activity on MRI
Among those initially randomly assigned to receive 1200 mg every 4 weeks, 96% were free of new gadolinium-positive lesions at 48 weeks.
Conference Coverage
Strategies for MS Fatigue and Sleep Issues
A multi-day cycle of high and low energy and mood can take hold in MS patients, but there are ways to counter it.
Conference Coverage
In MS With Mild Symptoms, Non-Motor Symptoms Predict Later Mobility Problems
The findings, seen only in patients with mild symptoms, could have implications for intervention programs.
Conference Coverage
A Simple Stress Intervention for MS
A stress management plan uses just four sessions and focuses on breathing and coping skills that patients can use on their own.
Conference Coverage
DMTs in Aging MS Patients: When and How to Stop
Changes to the immune system and the disease course can eliminate efficacy of DMTs, but it’s hard to know when to withdraw them.